a.amankwah

TL2 Moderator · Tampere

Contributes reviews on supplier material. Based in Tampere.

Joined 19 October 2024 · last posted 3d

77Posts here

2Topics

1Solutions

183Likes received

73Likes given

23Badges

63Days visited

801Posts read

Recent activity

Full stream

CJC-1295 with and without DAC: what the modification does Replied, post #122 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Which categories are strict and which are relaxed, honestly Replied, post #38 · Start Here › Welcome · 22 Jul 2026 · 28 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #119 · Outcomes › Body composition · 21 Jul 2026 · 21 likes post #118 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #6 · marked as the solution · Analytics › Mass spectrometry · 18 Jul 2026 · 9 likes This follows post #3 rather than contradicting it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect…
Seven-day rolling means and why weekly readings mislead Replied, post #45 · Outcomes › Progress reports · 17 Jul 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #30 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 9 likes Picking up post #27: that is the part I would want checked first. On integration: where the baseline is drawn matters more than most people realise. On a clean…
Documenting a supplier's response to a discrepancy Replied, post #29 · Sourcing › Vendor reports · 3 Jul 2026 · 7 likes post #28 answers the question as asked. The question underneath it is different. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #34 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 11 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
Primary endpoint hierarchies and why order matters — one year on Replied, post #28 · Evidence › Trials · 28 Jun 2026 · 2 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #48 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 31 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #13 · Analytics › Impurities & related substances · 20 Jun 2026 · 29 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #67 · Meta › Announcements · 19 Jun 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…